08/25/2025
3:31 PM | Mamlok Gilad (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/24/2025
11:15 PM | Protalix BioTherapeutics (Filer)
| Form EFFECT | |
08/22/2025
3:39 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2025
3:31 PM | Protalix BioTherapeutics (Filer)
| Form 424B5 | |
08/14/2025
5:58 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
6:05 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2025
6:10 AM | Protalix BioTherapeutics (Filer)
| Form S-3/A | |
08/12/2025
3:30 PM | Protalix BioTherapeutics (Issuer)
Schwartz Aharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
8:27 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
3:30 PM | Elze Christian (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2025
3:30 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for PLX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/09/2025
5:57 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
6:04 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
3:30 PM | Protalix BioTherapeutics (Filer)
| Form ARS | |
04/28/2025
4:00 PM | Protalix BioTherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/23/2025
3:30 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
4:19 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
6:18 AM | Protalix BioTherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/17/2025
5:55 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:30 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
6:01 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:03 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
5:57 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:00 PM | Protalix BioTherapeutics (Issuer)
Rubin Eyal (Reporting)
| Form 4/A | |
10/25/2024
3:23 PM | Protalix BioTherapeutics (Subject)
WHITEBOX ADVISORS LLC (Filed by)
| Form SC 13G/A | |
10/25/2024
7:27 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
4:00 PM | Naos Yaron (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
4:00 PM | Protalix BioTherapeutics (Issuer)
Rubin Eyal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access